About Droga5
Droga5 is a Business Services company based in Sydney (Australia) founded in 2008, and was acquired by Accenture in May 2017. Branding services are provided to clients in Sydney, Australia. Its chief executive, as recorded, is Jerry Keith. Its focus areas include Marketing Services and Branding Agencies.
Company details
Droga5 is recognized for providing creative and advertising solutions. The company is involved in various sectors requiring innovative marketing strategies. Specific details about services, target markets, or operational scope are not provided in the available content. Further information is needed to elaborate on their offerings and impact.
- Headquarters Sydney, Australia
- Stage Acquired
- SectorsBusiness Services
- Email••••••••
- Phone•••• ••••
- Website maud.com.au
- Social LinkedIn
- Acquired by Accenture (May 2017)
Investors in Droga5
Droga5 has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Accenture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
IT and management consultancy services are provided globally. | 1989 | accenture.com | Dublin, Ireland |
Investor details for Droga5
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Droga5
1 people are tracked at Droga5 (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jerry Keith | CEO | Leadership |
Complete people profiles for Droga5
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Droga5
2 dated milestones of Droga5 across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Droga5 is founded.
- Exit Acquired by Accenture.
Web traffic of Droga5
Websites that share an audience with Droga5 (maud.com.au).
Websites whose visitors overlap most with Droga5. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| finchbrands.com | 100% | #2,832,148 | View details | ||
| bluemarlinbd.com | 97% | 2.8K | #6,101,858 | View details | |
| strohlsf.com | 94% | 6.5K | #3,190,101 | View details | |
thomasmarsden.com.au | thomasmarsden.com.au | 55% | #12,194,378 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Droga5
Complete news archive for Droga5
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Droga5
Droga5 was founded in 2008.
Droga5 is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Jerry Keith is the CEO of Droga5, as recorded in our data.
Droga5 is recognized for providing creative and advertising solutions. The company is involved in various sectors requiring innovative marketing strategies. Specific details about services, target markets, or operational scope are not provided in the available content. Further information is needed to elaborate on their offerings and impact.
Droga5 has 1 investor. Key investors include Accenture.
Yes. Droga5 was acquired by Accenture in May 2017.